EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Brief Comparison of Novel Influenza Vaccine Design Strategies

Shiqi Chai, Chuantao Ye iD, Chao Fan, Hong Jiang iD

Vaccines · 15.11.2025 · 13 (11) · 1164

DOI: 10.3390/vaccines13111164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 15.11.2025. Verfasst von Shiqi Chai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Tangdu Hospital of the Fourth Military Medical University, Xi'an 710038, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Discipline Innovation and Development Program of Tangdu Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza viruses remain a major global public health concern, causing significant morbidity and mortality annually despite widespread vaccination efforts. The limitations of current seasonal vaccines, including strain-specific efficacy and manufacturing delays, have accelerated the development of next-generation candidates aiming for universal protection. This review comprehensively summarizes the recent progress in universal influenza vaccine research. We first outline the key conserved antigenic targets, such as the hemagglutinin (HA) stem, neuraminidase (NA), and matrix proteins (M2e, NP, and M1), which are crucial for eliciting broad cross-reactive immunity. We then delve into advanced antigen design strategies, including immunofocusing, multi-antigen combinations, computationally optimized broadly reactive antigens (COBRA), and nanoparticle-based platforms. Furthermore, we evaluate evolving vaccine delivery systems, from traditional inactivated and live-attenuated vaccines to modern mRNA and viral vector platforms, alongside the critical role of novel adjuvants in enhancing immune responses. The convergence of these disciplines—structural biology, computational design, and nanotechnology—is driving the field toward a transformative goal. We conclude that the successful development of a universal influenza vaccine will likely depend on the strategic integration of these innovative approaches to overcome existing immunological and logistical challenges, ultimately providing durable and broad-spectrum protection against diverse influenza virus strains.

Schlagwörter

Stichwörter der Autor:innen

delivery platformdesign strategiesinfluenzavaccinevirus

Autor:innen und Institutionen

  • Department of Infectious Diseases, Tangdu Hospital of the Fourth Military Medical University, Xi'an 710038, China.

ORCID-Profile: Chuantao Ye, Hong Jiang

Förderung

  • Discipline Innovation and Development Program of Tangdu Hospital

Zitieren

APA

Chai, S., Ye, C., Fan, C., & Jiang, H. (2025). Brief Comparison of Novel Influenza Vaccine Design Strategies. Vaccines, 13(11), 1164. https://doi.org/10.3390/vaccines13111164

Vancouver

Chai S, Ye C, Fan C, Jiang H. Brief Comparison of Novel Influenza Vaccine Design Strategies. Vaccines. 2025;13(11):1164. doi:10.3390/vaccines13111164

BibTeX
@article{Chai2025,
  author = {Chai, Shiqi and Ye, Chuantao and Fan, Chao and Jiang, Hong},
  title = {Brief Comparison of Novel Influenza Vaccine Design Strategies},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {11},
  pages = {1164},
  doi = {10.3390/vaccines13111164}
}
Kostenlos starten →